Antipsychotic pathway genes with expression altered in opposite direction by antipsychotics and amphetamine

Françoise Ko1, Teresa Tallerico, Philip Seeman

  • 1Department of Pharmacology, University of Toronto, Toronto, Ontario, Canada M5S 1A8.

Insights

Researchers identified 21 genes potentially linked to psychosis by comparing drug treatments in rats. This new strategy helps find antipsychotic-related pathway genes for further study.

Area of Science:

  • Neuroscience
  • Genetics
  • Pharmacology

Background:

  • Identifying genes related to psychosis and antipsychotic drug action is crucial for understanding mental health disorders.
  • Current methods for identifying these genes have limitations.

Purpose of the Study:

  • To develop a novel strategy for identifying potential psychosis- or antipsychotic-related pathway genes.
  • To find genes with specific expression patterns in response to antipsychotic drugs and amphetamine sensitization.

Main Methods:

  • Rats were administered clinical doses of haloperidol and clozapine for four days.
  • Gene expression changes were analyzed and compared with those from amphetamine-sensitized rats.
  • Genes exhibiting concordant alterations with antipsychotics and opposing alterations with amphetamine were selected.

Main Results:

  • Twenty-one genes met the specified criteria, indicating potential relevance to psychosis pathways.
  • Of these, 15 genes were upregulated by amphetamine, and 6 were downregulated.
  • Fifteen of the 21 identified genes are not yet characterized, and only three are located in known schizophrenia-associated chromosomal regions.

Conclusions:

  • The study presents a new strategy for identifying candidate genes involved in psychosis and antipsychotic drug response.
  • The identified genes, particularly the uncharacterized ones, represent promising targets for future research into schizophrenia and related disorders.

Related Concept Videos

Antipsychotic Drugs: Typical and Atypical Agents01:21

Antipsychotic Drugs: Typical and Atypical Agents

Antipsychotic drugs are classified into first-generation (typical) drugs including phenothiazines; and second-generation (atypical) drugs. Chlorpromazine hydrochloride (Thorazine), a phenothiazine derivative, broadly impacts the central, autonomic, and endocrine systems. This drug, along with typical agents like haloperidol (Haldol), primarily works by antagonizing D2 receptors, thus reducing dopaminergic neurotransmission. However, typical antipsychotics can cause side effects such as sedation...
Drugs Affecting Neurotransmitter Synthesis01:29

Drugs Affecting Neurotransmitter Synthesis

Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase, which converts...
Antipsychotic Drugs: Therapeutic Uses and Side Effects01:21

Antipsychotic Drugs: Therapeutic Uses and Side Effects

Antipsychotic drugs primarily block dopamine and serotonin receptors and cholinergic, adrenergic, and histaminergic receptors, thereby reducing hallucinations and delusions in conditions like schizophrenia. However, they can trigger unwanted extrapyramidal effects such as dystonias, Parkinson-like symptoms, and tardive dyskinesia.
Despite these side effects, antipsychotics are used therapeutically for various purposes, including managing schizophrenia, preventing nausea and vomiting, curbing...
Psychosis and Antipsychotic Drugs: Overview01:28

Psychosis and Antipsychotic Drugs: Overview

The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic symptoms in all...
Adrenergic Agonists: Indirect-Acting Agents01:25

Adrenergic Agonists: Indirect-Acting Agents

Indirect-acting adrenergic agonists potentiate the effects of endogenous catecholamines through different mechanisms without directly binding to adrenoceptors.
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral bioavailability, and...
Drugs Affecting Neurotransmitter Release or Uptake01:21

Drugs Affecting Neurotransmitter Release or Uptake

Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...